EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 3.0

Immune reprogramming of cold tumors using TGF-β/PD-L1 bispecific antibody and armed oncolytic virus therapy

Yuchen Sun, Shengtao Hu, Ming Yi, Zhijun Dai

Advances in Clinical and Experimental Medicine · 2025

DOI: 10.17219/acem/210993 ↗

Kurz gefasst

Editorial in der Zeitschrift Advances in Clinical and Experimental Medicine, 2025. Verfasst von Yuchen Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Oncolytic Virotherapy, Transforming Growth Factor beta, B7-H1 Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificOncolytic VirotherapyTransforming Growth Factor betaB7-H1 AntigenNeoplasmsImmunotherapyHumansTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

antibodiesbispecificimmunotherapyoncolytic virotherapytumor microenvironment

Substanzen

Antibodies, BispecificTransforming Growth Factor betaB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Zitieren

APA

Sun, Y., Hu, S., Yi, M., & Dai, Z. (2025). Immune reprogramming of cold tumors using TGF-β/PD-L1 bispecific antibody and armed oncolytic virus therapy. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/210993

Vancouver

Sun Y, Hu S, Yi M, Dai Z. Immune reprogramming of cold tumors using TGF-β/PD-L1 bispecific antibody and armed oncolytic virus therapy. Advances in Clinical and Experimental Medicine. 2025. doi:10.17219/acem/210993

BibTeX
@article{Sun2025,
  author = {Sun, Yuchen and Hu, Shengtao and Yi, Ming and Dai, Zhijun},
  title = {Immune reprogramming of cold tumors using TGF-β/PD-L1 bispecific antibody and armed oncolytic virus therapy},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2025},
  doi = {10.17219/acem/210993}
}
Kostenlos starten →